CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $247,777
- in 3 filings, $248K under 10b5-1 plans
Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-26 | Rhodes Jason P Director | Sale 10b5-1 | −11,736 | $23.59 | $277K | 909,107 |
| 2024-02-26 | Rhodes Jason P Director | Sale 10b5-1 | −5,580 | $23.98 | $134K | 903,527 |
| 2024-02-26 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −136,312 | $23.59 | $3.2M | 6,216,250 |
| 2024-02-26 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −64,783 | $23.98 | $1.6M | 6,151,467 |
| 2024-02-26 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −20,205 | $23.59 | $477K | 1,564,932 |
| 2024-02-26 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −9,603 | $23.98 | $230K | 1,555,329 |
| 2024-02-26 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −11,736 | $23.59 | $277K | 909,107 |
| 2024-02-26 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −5,580 | $23.98 | $134K | 903,527 |
| 2024-02-23 | Rhodes Jason P Director | Sale 10b5-1 | −159,542 | $22.70 | $3.6M | 6,352,562 |
| 2024-02-23 | Rhodes Jason P Director | Sale 10b5-1 | −23,648 | $22.70 | $537K | 1,585,137 |
| 2024-02-23 | Rhodes Jason P Director | Sale 10b5-1 | −13,738 | $22.70 | $312K | 920,843 |
| 2024-02-23 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −159,542 | $22.70 | $3.6M | 6,352,562 |
| 2024-02-23 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −23,648 | $22.70 | $537K | 1,585,137 |
| 2024-02-23 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −13,738 | $22.70 | $312K | 920,843 |
| 2024-02-22 | Rhodes Jason P Director | Sale 10b5-1 | −119,360 | $22.66 | $2.7M | 6,512,104 |
| 2024-02-22 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −119,360 | $22.66 | $2.7M | 6,512,104 |
| 2024-02-21 | Rhodes Jason P Director | Sale 10b5-1 | −149,337 | $22.44 | $3.4M | 6,666,628 |
| 2024-02-21 | Rhodes Jason P Director | Sale 10b5-1 | −35,164 | $23.14 | $814K | 6,631,464 |
| 2024-02-21 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −149,337 | $22.44 | $3.4M | 6,666,628 |
| 2024-02-21 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −35,164 | $23.14 | $814K | 6,631,464 |
Page 25 of 29 · 561 trades